Open AccessSubjective cognition and mood in persistent chemotherapy-related cognitive impairment
Author(s) -
Jennifer N. Vega,
Kimberly Albert,
Ingrid A. Mayer,
Warren D. Taylor,
Paul Newhouse
Publication year - 2021
Publication title -
journal of cancer survivorship
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.524
H-Index - 63
eISSN - 1932-2267
pISSN - 1932-2259
DOI - 10.1007/s11764-021-01055-1
Subject(s) - mood , cognition , clinical psychology , anxiety , medicine , randomized controlled trial , cognitive decline , effects of sleep deprivation on cognitive performance , psychiatry , psychology , dementia , disease
Persistent chemotherapy-related cognitive impairment (CRCI) is commonly reported following cancer treatment and negatively affects quality of life. While past research has focused on potential pathophysiological mechanisms underlying this relationship, the role of psychological factors, such as mood, stress, and anxiety, in the development of persistent CRCI has received less attention. As an additional analysis of data from a trial investigating the effects of transdermal nicotine patches on cognitive performance in patients with persistent CRCI, we examined whether change in mood was associated with changes in subjective and objective cognitive functioning.